Clinical Opportunities for Germline Pharmacogenetics and Management of Drug-Drug Interactions in Patients With Advanced Solid Cancers.
Tyler ShuggReynold C LyElizabeth J RoweSantosh PhilipsMustafa A HyderMilan RadovichMarc B RosenmanVictoria M PrattJohn T CallaghanZeruesenay DestaBryan Paul SchneiderTodd C SkaarPublished in: JCO precision oncology (2022)
Our findings demonstrate numerous clinical opportunities for germline PGx and DDI management in adults with advanced cancer.